CN Stock MarketDetailed Quotes
600812 North China Pharmaceutical
- 4.43
- -0.02-0.45%
Not Open Jul 29 15:00 CST
7.60BMarket Cap443.00P/E (TTM)
4.47High4.39Low59.64KlotVolume4.44Open4.45Pre Close26.46MTurnover0.35%Turnover Ratio1476.67P/E (Static)1.72BShares6.6552wk High1.43P/B7.60BFloat Cap3.8252wk Low4.90Limit Up1.72BShs Float20.14Historical High4.01Limit Down1.80%Amplitude0.62Historical Low0.01Dividend TTM4.44Avg Price27.34KlotAsk0.23%Div YieldTTM100Lot Size31.20KlotBid
North China Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -8.66%1.81B | -15.27%8.46B | -9.93%6.43B | -3.77%4.06B | -1.96%1.98B | 11.99%9.98B | 9.28%7.14B | -0.11%4.22B | 14.72%2.02B | -9.57%8.91B |
| Refunds of taxes and levies | 16.77%23.91M | -33.57%101.53M | -51.29%63.47M | -59.61%40.98M | -26.99%20.48M | 9.86%152.84M | 10.93%130.3M | 36.02%101.47M | -49.40%28.05M | 14.77%139.13M |
| Cash received relating to other operating activities | 673.27%443.3M | -15.15%198.11M | -51.82%151.14M | -44.37%106.72M | -38.84%57.33M | -30.43%233.48M | 6.77%313.7M | 8.70%191.83M | -55.63%93.74M | -34.52%335.6M |
| Cash inflows from operating activities | 10.62%2.27B | -15.54%8.76B | -12.37%6.64B | -6.75%4.21B | -3.90%2.06B | 10.44%10.37B | 9.20%7.58B | 0.84%4.51B | 5.62%2.14B | -10.51%9.39B |
| Goods services cash paid | 4.19%860.48M | -26.25%3.98B | -25.29%3.03B | -18.46%1.87B | -21.12%825.9M | 25.46%5.4B | 24.15%4.06B | 12.41%2.3B | 32.21%1.05B | -7.11%4.31B |
| Staff behalf paid | 7.02%334.89M | -9.26%1.36B | -4.28%969.04M | -7.66%634.97M | -16.33%312.91M | 23.30%1.49B | 9.32%1.01B | 9.98%687.64M | 11.38%373.96M | -8.77%1.21B |
| All taxes paid | -40.24%111.3M | 6.86%608.46M | 13.11%495.41M | 23.57%341.65M | 7.76%186.23M | -6.58%569.41M | -2.37%438M | -9.60%276.48M | 15.40%172.82M | -8.36%609.5M |
| Cash paid relating to other operating activities | -26.31%399.51M | -5.99%1.78B | 0.90%1.55B | 7.14%1.09B | 6.84%542.17M | -14.14%1.9B | -7.06%1.54B | -18.83%1.02B | -28.02%507.45M | -28.91%2.21B |
| Cash outflows from operating activities | -8.62%1.71B | -17.42%7.73B | -14.17%6.05B | -7.91%3.94B | -11.14%1.87B | 12.31%9.36B | 11.87%7.05B | 1.18%4.28B | 5.99%2.1B | -14.38%8.34B |
| Net cash flows from operating activities | 201.87%567.08M | 1.98%1.02B | 11.39%593.73M | 14.75%264.99M | 404.11%187.86M | -4.37%1B | -17.04%533.02M | -5.08%230.93M | -11.82%37.27M | 39.63%1.05B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received from returns on investments | ---- | -31.51%589.47K | --589.47K | ---- | ---- | -49.03%860.71K | --0 | ---- | ---- | -91.08%1.69M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -96.90%690.95K | -96.87%690.95K | -98.30%373.4K | -53.01%230K | 240.18%22.26M | 2,194.38%22.05M | 2,189.19%21.98M | --489.42K | -95.39%6.54M |
| Cash inflows from investing activities | ---- | -94.46%1.28M | -94.19%1.28M | -98.30%373.4K | -53.01%230K | 180.85%23.12M | 1,124.40%22.05M | 1,121.03%21.98M | --489.42K | -94.96%8.23M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 64.17%192.68M | 13.36%623.04M | -3.76%380.13M | 25.17%257.48M | 10.54%117.37M | 0.38%549.58M | -3.40%394.99M | -30.74%205.7M | -23.89%106.18M | -45.62%547.5M |
| Cash paid to acquire investments | ---- | 12,900.00%260M | --50M | ---- | ---- | -99.17%2M | ---- | ---- | ---- | --240M |
| Cash outflows from investing activities | 64.17%192.68M | 60.09%883.04M | 8.90%430.13M | 25.17%257.48M | 10.54%117.37M | -29.96%551.58M | -39.13%394.99M | -61.69%205.7M | -23.89%106.18M | -21.78%787.5M |
| Net cash flows from investing activities | -64.49%-192.68M | -66.85%-881.75M | -14.99%-428.85M | -39.94%-257.1M | -10.83%-117.14M | 32.18%-528.46M | 42.37%-372.94M | 65.67%-183.72M | 24.24%-105.69M | 7.62%-779.26M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | 68.29%10M | ---- | ---- | ---- | --5.94M | ---- | ---- | ---- | --0 |
| Cash from borrowing | -34.91%1.85B | -4.30%9.83B | -1.04%7.3B | -22.85%4.66B | -19.24%2.84B | 0.19%10.27B | -2.12%7.38B | 25.35%6.04B | 42.15%3.51B | -31.53%10.25B |
| Cash received relating to other financing activities | -41.51%176.51M | -25.03%945.44M | -29.98%914.77M | -32.92%842.77M | -57.29%301.8M | 5.80%1.26B | 32.71%1.31B | 114.98%1.26B | 412.71%706.62M | 171.93%1.19B |
| Cash inflows from financing activities | -35.55%2.02B | -6.53%10.78B | -5.39%8.22B | -24.58%5.5B | -25.61%3.14B | 0.82%11.54B | 1.90%8.68B | 35.05%7.3B | 61.73%4.22B | -31.76%11.44B |
| Borrowing repayment | -19.27%1.92B | -27.57%9.58B | -28.81%6.87B | -32.24%4.31B | -37.36%2.38B | 38.56%13.23B | 60.10%9.65B | 79.98%6.36B | 123.15%3.79B | -17.08%9.55B |
| Dividend interest payment | -9.82%118.5M | -30.39%516.22M | -39.96%367.47M | -20.89%279.23M | -21.79%131.41M | -0.69%741.6M | 9.85%612M | 3.02%352.96M | 5.15%168.01M | 13.69%746.79M |
| Cash payments relating to other financing activities | 47.48%475.79M | -32.03%1.39B | -25.96%1.28B | -38.34%978.7M | -65.16%322.61M | 145.07%2.05B | 97.58%1.73B | 193.52%1.59B | 552.74%926.1M | -28.46%835.19M |
| Cash outflows from financing activities | -11.22%2.51B | -28.27%11.49B | -28.97%8.52B | -32.92%5.57B | -42.10%2.83B | 43.92%16.02B | 60.74%12B | 87.91%8.3B | 144.18%4.89B | -16.56%11.13B |
| Net cash flows from financing activities | -258.62%-489.39M | 84.28%-704.14M | 90.78%-305.23M | 93.33%-67.15M | 146.19%308.53M | -1,523.69%-4.48B | -412.85%-3.31B | -202.40%-1.01B | -210.00%-667.91M | -90.84%314.58M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 295.05%2.48M | 43.01%12.07M | -21.32%9.18M | 101.96%7.51M | -1,302.31%-1.27M | 369.18%8.44M | 1,056.83%11.66M | 392.27%3.72M | 81.49%-90.57K | 71.87%-3.13M |
| Net increase in cash and cash equivalents | -129.77%-112.51M | 86.24%-549.56M | 95.82%-131.18M | 94.59%-51.76M | 151.33%377.97M | -785.80%-3.99B | -398.28%-3.14B | -238.49%-956.55M | -244.55%-736.43M | -82.51%582.42M |
| Add:Begin period cash and cash equivalents | -52.11%505M | -79.11%1.05B | -79.11%1.05B | -79.11%1.05B | -79.11%1.05B | 13.04%5.05B | 13.04%5.05B | 13.04%5.05B | 13.04%5.05B | 293.32%4.47B |
| End period cash equivalent | -72.60%392.49M | -52.11%505M | -51.61%923.39M | -75.50%1B | -66.78%1.43B | -79.11%1.05B | -65.42%1.91B | -20.65%4.09B | -13.33%4.31B | 13.04%5.05B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Zhongtianyun Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongtianyun Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongtianyun Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg